GENZYME THERAPEUTICS LIMITED

Active Reading

Non-trading company

2 employees website.com
Life sciences and medical technology Non-trading company
G

GENZYME THERAPEUTICS LIMITED

Non-trading company

Founded 5 Nov 2001 Active Reading, England 2 employees website.com
Life sciences and medical technology Non-trading company

Previous Company Names

TAYVIN 248 LIMITED 5 Nov 2001 — 21 Dec 2001
Accounts Submitted 12 Dec 2025 Next due 30 Sept 2026 5 months remaining
Confirmation Submitted 5 Jan 2026 Next due 14 Jan 2027 8 months remaining
Net assets £47M £0 2024 year on year
Total assets £51M £0 2024 year on year
Total Liabilities £4M £0 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

410 Thames Valley Park Drive Reading Berkshire RG6 1PT England

Website

www.example.com

Full company profile for GENZYME THERAPEUTICS LIMITED (04316333), an active life sciences and medical technology company based in Reading, England. Incorporated 5 Nov 2001. Non-trading company. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Balance Sheet & P&L (2014–2024)

Cash in Bank

N/A

Net Assets

£47.04M

Total Liabilities

£3.59M

Turnover

N/A

Employees

2

Debt Ratio

7%

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

1 active 2 resigned
Status
Usman KhanDirectorBritishUnited Kingdom4631 Mar 2021Active

Shareholders

Shareholders (1)

Aventis Pharma Limited
100.0%

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Aventis Pharma Limited

United Kingdom

Active
Notified 30 Apr 2019
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors
Ceased

Group Structure

Group Structure

GENZYME THERAPEUTICS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
5 Feb 2026OfficersTermination of Rippondeep Ubhi as director on 2026-02-01
5 Feb 2026OfficersAppointment of Mr Ahmed Mohamed Moustafa Moussa as director on 2026-02-01
5 Feb 2026OfficersTermination of Usman Khan as director on 2026-02-01
5 Feb 2026OfficersAppointment of Walaa Mostafa Abbas Awad Mohamed as director on 2026-02-01
5 Jan 2026Confirmation StatementConfirmation statement made on 2025-12-31 with no updates
5 Feb 2026 Officers

Termination of Rippondeep Ubhi as director on 2026-02-01

5 Feb 2026 Officers

Appointment of Mr Ahmed Mohamed Moustafa Moussa as director on 2026-02-01

5 Feb 2026 Officers

Termination of Usman Khan as director on 2026-02-01

5 Feb 2026 Officers

Appointment of Walaa Mostafa Abbas Awad Mohamed as director on 2026-02-01

5 Jan 2026 Confirmation Statement

Confirmation statement made on 2025-12-31 with no updates

Recent Activity

Latest Activity

Termination of Rippondeep Ubhi as director on 2026-02-01

2 months ago on 5 Feb 2026

Appointment of Mr Ahmed Mohamed Moustafa Moussa as director on 2026-02-01

2 months ago on 5 Feb 2026

Termination of Usman Khan as director on 2026-02-01

2 months ago on 5 Feb 2026

Appointment of Walaa Mostafa Abbas Awad Mohamed as director on 2026-02-01

2 months ago on 5 Feb 2026

Confirmation statement made on 2025-12-31 with no updates

3 months ago on 5 Jan 2026